Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

RESTORE trial results presented at AHA meeting

Nov. 22, 1996

New market introduction for ReoPro

Nov. 22, 1996

Antithrombotic/antiallergic agents from Terumo

Nov. 22, 1996

Genetics Institute's factor IX scheduled for review

Nov. 21, 1996

Clinical trial compares therapeutic potential of heparin and hirudin in coronary thrombosis

Nov. 21, 1996

Hirudin-based thrombin inhibitors reported by Canadian investigators

Nov. 19, 1996

CAPRIE study demonstrates clopidogrel more effective than aspirin

Nov. 15, 1996

Preclinical and clinical pharmacological profile of efegatran

Nov. 15, 1996

Ciba-Geigy describes trypsin/thrombin inhibitors

Nov. 15, 1996

FDA clears new heart attack drug

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...